Immunotherapy better than aggressive chemo as first-line treatment in head and neck cancer

Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show.

* This article was originally published here